Last reviewed · How we verify

NCT04298736: BeLEANeR

Bariatric Surgery vs. Lifestyle Modification for NASH

Status unknown NA Last updated 6 March 2020
What this trial tests

NA trial testing Bariatric Surgery in NASH - Nonalcoholic Steatohepatitis in 50 participants. Status unknown.

Timeline
19 February 2020
Primary endpoint
20 March 2022
20 March 2022

Quick facts

Lead sponsorHospital de Clinicas de Porto Alegre
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date19 February 2020
Primary completion20 March 2022
Estimated completion20 March 2022
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Hospital de Clinicas de Porto Alegre

Who can join

Adults 18 to 65, any sex, with NASH - Nonalcoholic Steatohepatitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized Controlled Trial comparing the effects of Bariatric Surgery vs. Lifestyle modification on NASH resolution.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bariatric Surgery

Trials testing the same drug.

Other recruiting trials for NASH - Nonalcoholic Steatohepatitis

Currently open trials in the same condition.

Other Hospital de Clinicas de Porto Alegre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04298736.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing